RICHMOND – It seems backwards, testing a drug for safety after it has been approved. But some researchers now are beginning to see the benefits.

“Everyone is looking at how can we study drugs post-marketing,” says Jürgen Venitz, MD, Ph.D. and Associate Professor, Department of Pharmaceutics, School of Pharmacy at Virginia Commonwealth University / Medical College of Virginia. (more…)